These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34295412)

  • 1. The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis.
    Maetz J; Denning J
    Breathe (Sheff); 2021 Mar; 17(1):210013. PubMed ID: 34295412
    [No Abstract]   [Full Text] [Related]  

  • 2. The dance of cystic fibrosis: Experiences of living with cystic fibrosis as an adult.
    Varilek BM; Isaacson MJ
    J Clin Nurs; 2020 Sep; 29(17-18):3553-3564. PubMed ID: 32608531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres.
    Muhlebach MS; Cunningham F; LiPuma JJ; Zhou JJ; Saiman L
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34646879
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of massive haemoptysis after a first episode of mild-to-moderate haemoptysis in patients with cystic fibrosis.
    Pavaut G; Kyheng M; Le Rouzic O; Perez T; Wallaert B; Prevotat A
    ERJ Open Res; 2020 Jul; 6(3):. PubMed ID: 32963988
    [No Abstract]   [Full Text] [Related]  

  • 5. Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis.
    Chalmers JD; Metersky ML; Feliciano J; Fernandez C; Teper A; Maes A; Hassan M; Chatterjee A
    ERJ Open Res; 2023 Jul; 9(3):. PubMed ID: 37143828
    [No Abstract]   [Full Text] [Related]  

  • 6. Would it have happened without Christmas? Thoracic emphysema and allergic bronchopulmonary aspergillosis in a juvenile cystic fibrosis patient with the G551D mutation receiving ivacaftor.
    Mainz JG; Erdmann N; Duckstein F; Zagoya C
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34046494
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic Fibrosis: Translating Molecular Mechanisms into Effective Therapies.
    Jennings MT; Flume PA
    Ann Am Thorac Soc; 2018 Aug; 15(8):897-902. PubMed ID: 29812963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do cystic fibrosis patients experience parenthood? A systematic review.
    Jacob A; Journiac J; Fischer L; Astrologo L; Flahault C
    J Health Psychol; 2021 Jan; 26(1):60-81. PubMed ID: 32431218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystic fibrosis -- disease burden and health-related quality of life of patients and their caregivers: results of the European BURQOL-RD survey in Hungary].
    Péntek M; Kosztolányi G; Melegh B; Halász A; Pogány G; Baji P; Brodszky V; Vártokné Hevér N; Boncz I; Gulácsi L
    Orv Hetil; 2014 Oct; 155(42):1673-84. PubMed ID: 25305725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parents of children with cystic fibrosis: how they hope, cope and despair.
    Wong MG; Heriot SA
    Child Care Health Dev; 2008 May; 34(3):344-54. PubMed ID: 18294259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis.
    Deschamp AR; Pettit RS; Donaldson JA; Slaven JE; Davis SD
    SAGE Open Med; 2017; 5():2050312117736694. PubMed ID: 29085640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Quality of Life in Terms of Sinonasal Symptoms in Children with Cystic Fibrosis.
    Hassanzad M; Derakhshan KF; Ghaffaripour H; Naeini AS; Emami H; Velayati AA
    Biomol Concepts; 2019 Jun; 10(1):91-98. PubMed ID: 31226098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the management of cystic fibrosis.
    Davies JC; Ebdon AM; Orchard C
    Arch Dis Child; 2014 Nov; 99(11):1033-6. PubMed ID: 24996790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One breath at a time: living with cystic fibrosis.
    Rinaldi Carpenter D; Narsavage GL
    J Pediatr Nurs; 2004 Feb; 19(1):25-32. PubMed ID: 14963867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Levels of Education Are Associated With Full-Time Work in Adults With Cystic Fibrosis.
    Lian R; Cavalheri V; Wood J; Jenkins S; Straker LM; Hill K
    Respir Care; 2019 Sep; 64(9):1116-1122. PubMed ID: 30890629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cystic fibrosis as seen from the patients' perspective].
    Wahl AK; Rustøen T; Gjengedal E; Homme J; Hanestad BR
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2580-2. PubMed ID: 14714048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in the therapy of non-cystic fibrosis bronchiectasis.
    Amorim A; Gamboa F; Azevedo P
    Rev Port Pneumol; 2013; 19(6):266-75. PubMed ID: 23850192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Bhatt J; Jahnke N; Smyth AR
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.